-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Soleno Therapeutics, Raises Price Target to $120

Benzinga·01/20/2026 11:48:13
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Soleno Therapeutics (NASDAQ:SLNO) with a Buy and raises the price target from $110 to $120.